Ulipristal versus levonorgestrel for emergency contraception a review of comparative cost-effectiveness
A previous CADTH report reviewed the comparative clinical effectiveness and guidelines on the emergency contraception (EC) use of ulipristal acetate versus levonorgestrel. The aim of this report is to review the comparative cost-effectiveness of those two EC drugs
Main Authors: | , |
---|---|
Corporate Authors: | , |
Format: | eBook |
Language: | English |
Published: |
Ottawa
CADTH
2019, February 12, 2019
|
Edition: | Version 1.0 |
Series: | CADTH rapid response report: summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | A previous CADTH report reviewed the comparative clinical effectiveness and guidelines on the emergency contraception (EC) use of ulipristal acetate versus levonorgestrel. The aim of this report is to review the comparative cost-effectiveness of those two EC drugs |
---|---|
Physical Description: | 1 PDF file (x pages) illustrations |